Patients taking to the Internet for information about testosterone replacement therapy are likely getting an incomplete picture of the potential risks and adverse effects linked with the treatment, say researchers from Northwestern University Feinberg School of Medicine, Chicago, and the University of Pennsylvania, Philadelphia.
Dr. Kapoor, LUGPA’s chairman of health policy, explains the basis of his recent JAMA letter supporting the in-office ancillary services exception to the Stark law.
This slideshow roundup includes some of the most prominent Twitter participants from AUA 2015 (along with a sampling of their tweets).
Panelists and audience members at the recent AUA “crossfire” debate on focal therapy show why the treatment is so controversial.
The cell surface amino acid glypican-1 (GPC-1) represents a potential new biomarker for prostate cancer, said Jonathan Henderson, MD, at the AUA annual meeting.
A change in how stricture is managed in the U.S. is evident, both among young urologists and over time.
Do you know the two most common reasons urologists are sued for malpractice?
A novel metric for evaluating post-prostatectomy outcomes could support quality improvement initiatives for optimizing patient recovery.
Greater use of culture-directed care represents an opportunity to improve management of women with uncomplicated UTIs, researchers say.
US News & World Report rankings may have no relevance to clinical outcomes of renal transplant programs.
On January 10, 2015 Urology Times convened an expert panel to examine the criteria that constitute a gold standard for the treatment of male lower urinary tract symptoms (LUTS), or benign prostatic hyperplasia (BPH).
Despite our best efforts, we make mistakes and complications occur, says blogger Henry Rosevear, MD. It is simply part of a physician’s job, but it is not a part that Dr. Rosevear is comfortable with. Nevertheless, dealing with complications and grieving are normal, and he offers some advice based on lessons learned.
Recently published research on a novel chemotherapy-immunotherapy combination is “exciting for multiple reasons,” says one expert.
A new study assesses how a biopsy-based gene test impacts prostate cancer treatment recommendations in three high-volume practices.
Products in the pipeline for prostate cancer, bladder cancer, and much more.
Post-radical prostatectomy radiation therapy in patients at risk of prostate cancer recurrence is on the wane in the U.S., despite evidence and guidelines supporting the practice, recently published research indicates.
An experimental drug that stabilizes a protein protects human bladder cells against a major UTI pathogen, researchers say.
Having completed a well-deserved victory lap after the recent repeal of the SGR, it's time to tune up our engines and head right back to the race track to advance the specialty's remaining advocacy priorities.
Hear what urologists are doing to enhance their income and practice.
Finally, I can stop writing about the Medicare SGR formula and efforts to reform it, and you can stop worrying about whether you’re going to get whacked with untenable payment cuts about this time every year.
A patient follow-up report shows promising mid-term results from five German urology centers that implemented the prostatic urethral lift (UroLift System, NeoTract, Inc.) to alleviate symptomatic BPH in patients suffering from mild, moderate, and even severe obstruction.
Biomarker models to predict disease progression in prostate cancer have a promising future, but at present, they have not fully justified their claimed clinical utilities, according to the authors of an independent review and analysis of the literature.
Near-infrared fluorescence-guided selective clamping with indocyanine green fluorescent dye in robot-assisted partial nephrectomy appears to be a promising technique to delineate renal tumor anatomy for the bloodless resection of renal masses while minimizing ischemic damage to the kidney.
Not-so-obvious coding errors and self-referral practices are a growing target for the government and contractors, health care attorneys say.
What can urologists do to protect themselves from being accused of and charged with health care fraud and abuse? Urologist Jeffrey Kaufman, MD, and attorneys J.D. Thomas, Esq and Laura F. Laemmle-Weidenfeld, Esq provide these four suggestions.
Laser photoselective vaporization prostatectomy using a 180W 532-nm lithium triborate laser (GreenLight XPS-180W laser system, American Medical Systems) is a safe and efficient option for treating BPH in men at high risk for surgical complications, according to findings from a large, international retrospective analysis.
Remaining on preventive antiplatelet therapy with aspirin significantly increases the risk of bleeding complications in patients undergoing partial nephrectomy, according to research presented at the European Association of Urology annual congress in Madrid, Spain.
In this article, Robert A. Dowling, MD, discusses additional opportunities for urologists to improve the safety of care in their own practices in the context of the NQF best practices.
In this Coding Q&A column, the Painters discuss the tricky question of whether you can bill for stone prevention counseling, and also answer a question about whether you can bill two instillation codes (51700) for one appointment.
Other products featured include a spacer system to protect men undergoing PCa radiotherapy, a pelvic floor exercise app, and more.